{
  "company_number": "07871679",
  "name": "NGS Pharma Ltd",
  "url": "/company/07871679",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2011-12-05",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "47730",
      "description": "Dispensing chemist in specialised stores",
      "section": "G",
      "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles",
      "url": "/sic/47730"
    }
  ],
  "registered_address": {
    "id": 462027,
    "url": "/address/462027",
    "line1": "39 CHAPEL ROAD",
    "line2": "WEST BERGHOLT",
    "post_town": "COLCHESTER",
    "county": "ESSEX",
    "country": "ENGLAND",
    "postcode": "CO6 3JB"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07871679",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2026-12-31",
    "last_made_up": "2025-03-31",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/07871679/accounts/2025-03-31",
        "pdf_url": "/company/07871679/accounts/2025-03-31.pdf",
        "made_up_date": "2025-03-31",
        "period_start": "2025-03-31",
        "period_end": "2025-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": "7.00",
        "tangible_fixed_assets": "125581.00",
        "debtors": "316646.00",
        "cash_bank_in_hand": "798910.00",
        "current_assets": "1208996.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "948698.00",
        "total_assets_less_current_liabilities": "1074279.00",
        "net_assets_liabilities": "1063646.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "1063546.00",
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2026.zip"
      },
      {
        "url": "/company/07871679/accounts/2024-03-31",
        "pdf_url": "/company/07871679/accounts/2024-03-31.pdf",
        "made_up_date": "2024-03-31",
        "period_start": "2024-03-31",
        "period_end": "2024-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": "7.00",
        "tangible_fixed_assets": "120401.00",
        "debtors": "332074.00",
        "cash_bank_in_hand": "820786.00",
        "current_assets": "1246827.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "931839.00",
        "total_assets_less_current_liabilities": "1052240.00",
        "net_assets_liabilities": "1032807.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2024.zip"
      },
      {
        "url": "/company/07871679/accounts/2023-03-31",
        "pdf_url": "/company/07871679/accounts/2023-03-31.pdf",
        "made_up_date": "2023-03-31",
        "period_start": "2023-03-31",
        "period_end": "2023-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": "7.00",
        "tangible_fixed_assets": "1479.00",
        "debtors": "316287.00",
        "cash_bank_in_hand": "784310.00",
        "current_assets": "1190789.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "945254.00",
        "total_assets_less_current_liabilities": "946733.00",
        "net_assets_liabilities": "917300.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2024.zip"
      },
      {
        "url": "/company/07871679/accounts/2022-03-31",
        "pdf_url": "/company/07871679/accounts/2022-03-31.pdf",
        "made_up_date": "2022-03-31",
        "period_start": "2022-03-31",
        "period_end": "2022-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": "7.00",
        "tangible_fixed_assets": "1459.00",
        "debtors": "362656.00",
        "cash_bank_in_hand": "581705.00",
        "current_assets": "1038564.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "819801.00",
        "total_assets_less_current_liabilities": "821260.00",
        "net_assets_liabilities": "771260.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2022.zip"
      },
      {
        "url": "/company/07871679/accounts/2021-03-31",
        "pdf_url": "/company/07871679/accounts/2021-03-31.pdf",
        "made_up_date": "2021-03-31",
        "period_start": "2020-04-01",
        "period_end": "2021-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": "10.00",
        "tangible_fixed_assets": "927.00",
        "debtors": "345375.00",
        "cash_bank_in_hand": "505987.00",
        "current_assets": "945521.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "664835.00",
        "total_assets_less_current_liabilities": "665762.00",
        "net_assets_liabilities": "572535.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": "160647.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2021.zip"
      },
      {
        "url": "/company/07871679/accounts/2020-03-31",
        "pdf_url": "/company/07871679/accounts/2020-03-31.pdf",
        "made_up_date": "2020-03-31",
        "period_start": "2020-03-31",
        "period_end": "2020-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": "9.00",
        "tangible_fixed_assets": "5610.00",
        "debtors": "423464.00",
        "cash_bank_in_hand": "298091.00",
        "current_assets": "814465.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "511766.00",
        "total_assets_less_current_liabilities": "517376.00",
        "net_assets_liabilities": "471888.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-February2021.zip"
      },
      {
        "url": "/company/07871679/accounts/2019-03-31",
        "pdf_url": "/company/07871679/accounts/2019-03-31.pdf",
        "made_up_date": "2019-03-31",
        "period_start": "2019-03-31",
        "period_end": "2019-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "10655.00",
        "debtors": "359359.00",
        "cash_bank_in_hand": "392070.00",
        "current_assets": "837309.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "507838.00",
        "total_assets_less_current_liabilities": "518493.00",
        "net_assets_liabilities": "423810.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2019.zip"
      },
      {
        "url": "/company/07871679/accounts/2018-03-31",
        "pdf_url": "/company/07871679/accounts/2018-03-31.pdf",
        "made_up_date": "2018-03-31",
        "period_start": "2018-03-31",
        "period_end": "2018-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "16223.00",
        "debtors": "248968.00",
        "cash_bank_in_hand": "438175.00",
        "current_assets": "762471.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "363550.00",
        "total_assets_less_current_liabilities": "379773.00",
        "net_assets_liabilities": "241248.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2018.zip"
      },
      {
        "url": "/company/07871679/accounts/2017-03-31",
        "pdf_url": "/company/07871679/accounts/2017-03-31.pdf",
        "made_up_date": "2017-03-31",
        "period_start": "2017-03-31",
        "period_end": "2017-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "4169.00",
        "debtors": "260887.00",
        "cash_bank_in_hand": "435999.00",
        "current_assets": "763861.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "286872.00",
        "total_assets_less_current_liabilities": "291041.00",
        "net_assets_liabilities": "113522.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2017.zip"
      },
      {
        "url": "/company/07871679/accounts/2016-03-31",
        "pdf_url": "/company/07871679/accounts/2016-03-31.pdf",
        "made_up_date": "2016-03-31",
        "period_start": "2016-03-31",
        "period_end": "2016-03-31",
        "entity_name": "NGS Pharma Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "5703.00",
        "debtors": "237985.00",
        "cash_bank_in_hand": "387061.00",
        "current_assets": "687432.00",
        "creditors_due_within_one_year": "469164.00",
        "creditors_due_after_one_year": "219410.00",
        "net_current_assets_liabilities": "218268.00",
        "total_assets_less_current_liabilities": "223971.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "4461.00",
        "shareholder_funds": "4561.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-November2016.zip"
      }
    ],
    "pdf_only_filings": [
      {
        "made_up_date": "2015-03-31",
        "filing_date": "2016-01-09",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-small",
        "paper_filed": true,
        "pdf_url": "/company/07871679/accounts/2015-03-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07871679/filing-history/MzEzODg4Nzk0OGFkaXF6a2N4/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2014-03-31",
        "filing_date": "2014-12-22",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-small",
        "paper_filed": true,
        "pdf_url": "/company/07871679/accounts/2014-03-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07871679/filing-history/MzExMzc4OTk5N2FkaXF6a2N4/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2013-03-31",
        "filing_date": "2013-12-30",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-small",
        "paper_filed": true,
        "pdf_url": "/company/07871679/accounts/2013-03-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07871679/filing-history/MzA5MTY0NjA4NWFkaXF6a2N4/document?format=pdf&download=0"
      }
    ],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07871679/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2026-12-19",
    "last_made_up": "2025-12-05"
  },
  "officers": [],
  "psc": [
    {
      "name": "Mr Nikunj Gunvantrai Shah",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/3711693",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent",
        "voting-rights-75-to-100-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-09-01",
    "retrieved_at": "2026-09-09T05:59:12.582323+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}